Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD)

CUSIP: 67577R102

Q2 2026 13F Holders as of 30 Jun 2026

Holder snapshot 6 signals
Share change
+24,147
SEC-reported price per share
$4.11
Number of holders
14
Value change
+$87,563
Number of buys
8
Number of sells
3
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
81,377,060

Security key

67577R102

Report period

Q2 2026

Institutions

14

Top holders

10

Ownership snapshot

Top reported holders of IRD - Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
PERCEPTIVE ADVISORS LLC
Disclosed value leader
PERCEPTIVE ADVISORS LLC
Comparable rows
15/15
Latest evidence
18 May 2026
13D/G 13F 3/4/5 Lead comparable stake: 10% 13D/G row: PERCEPTIVE ADVISORS LLC Showing 1-6 of 15 holder rows.

Quick read

PERCEPTIVE ADVISORS LLC leads the comparable SEC ownership view at 10%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens PERCEPTIVE ADVISORS LLC's linked filing trail.
Comparable ownership Top 5
PERCEPTIVE ADVISORS LLC 10%
Caligan Partners LP 8.5%
Adage Capital Management, L.P. 8.5%
BALYASNY ASSET MANAGEMENT L.P. 7.2%
Nantahala Capital Management, LLC 6.5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
PERCEPTIVE ADVISORS LLC
13D/G 13F
Company
10%
$43,444,313
8,830,145 shares
+$8,147,476 31 Mar 2026
Caligan Partners LP
13D/G 13F
Company
8.5%
$29,889,138
6,075,028 shares
$0 31 Mar 2026
Adage Capital Management, L.P.
13D/G
8.5%
$29,666,493
6,029,775 shares
$0 31 Mar 2026
BALYASNY ASSET MANAGEMENT L.P.
13D/G 13F
Company
7.2%
$25,143,035
5,110,373 shares
$0 31 Mar 2026
Nantahala Capital Management, LLC
13D/G 13F
Company
6.5%
$23,808,987
4,839,225 shares
-$11,238,663 31 Mar 2026
Foundation Fighting Blindness Retinal Degeneration Fund
13D/G 3/4/5
Director, Other*
4.7%
$17,709,439
3,792,171 shares
-$7,939,000 18 May 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
14
Shares
121,970
Rows available
14
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders
77
Q2 2026 holders
14
Holder diff
-63
Investor Q1 2026 Shares Q2 2026 Shares Share Diff Share Chg % Q1 2026 value Q2 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .